Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply

Maartje W Rohaan; Rob Kessels; John B A G Haanen

doi:10.1056/NEJMc2300132

Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply

Maartje W Rohaan
, Rob Kessels
, John B A G Haanen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	859-860
Number of pages	2
Journal	The New England journal of medicine
Volume	388
Issue number	9
DOIs	https://doi.org/10.1056/NEJMc2300132
Publication status	Published - 2 Mar 2023
Externally published	Yes

Keywords

Humans
Ipilimumab
Lymphocytes, Tumor-Infiltrating
Melanoma
Cell- and Tissue-Based Therapy
Immunotherapy, Adoptive

Access to Document

10.1056/NEJMc2300132

Cite this

@article{af8271d8bca34c83ae44c1909cef736e,

title = "Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply",

keywords = "Humans, Ipilimumab, Lymphocytes, Tumor-Infiltrating, Melanoma, Cell- and Tissue-Based Therapy, Immunotherapy, Adoptive",

author = "Rohaan, \{Maartje W\} and Rob Kessels and Haanen, \{John B A G\}",

year = "2023",

month = mar,

day = "2",

doi = "10.1056/NEJMc2300132",

language = "English",

volume = "388",

pages = "859--860",

journal = "The New England journal of medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "9",

}

TY - JOUR

T1 - Tumor-Infiltrating Lymphocyte Therapy in Advanced Melanoma. Reply

AU - Rohaan, Maartje W

AU - Kessels, Rob

AU - Haanen, John B A G

PY - 2023/3/2

Y1 - 2023/3/2

KW - Humans

KW - Ipilimumab

KW - Lymphocytes, Tumor-Infiltrating

KW - Melanoma

KW - Cell- and Tissue-Based Therapy

KW - Immunotherapy, Adoptive

U2 - 10.1056/NEJMc2300132

DO - 10.1056/NEJMc2300132

M3 - Article

C2 - 36856631

SN - 0028-4793

VL - 388

SP - 859

EP - 860

JO - The New England journal of medicine

JF - The New England journal of medicine

IS - 9

ER -